Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLHDC3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | EFCAB2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | NTMT1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | NPIPA5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | CALML3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | GPR137C | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | PTBP2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | UGT2A1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
mRNA | ANKRD63 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
mRNA | UGT2A2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |